Roberta Possenti
Rome, 00173, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma.
Journal: Oncology letters
Published: July 05, 2023
What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
Journal: Neuroscience and biobehavioral reviews
Published: June 22, 2021
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity.
Journal: Cells
Published: November 12, 2020
TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.
Journal: International journal of molecular sciences
Published: December 02, 2019
Neuropeptides in Alzheimer's Disease: An Update.
Journal: Current Alzheimer research
Published: January 23, 2019
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.
Journal: Frontiers in pharmacology
Published: December 21, 2016
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization.
Journal: Neuropharmacology
Published: October 05, 2016
JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells.
Journal: Frontiers in cellular neuroscience
Published: October 04, 2016
The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose homeostasis.
Journal: Journal of molecular endocrinology
Published: April 09, 2015
The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.
Journal: Structure (London, England : 1993)
Published: June 02, 2014
Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-β-induced toxicity.
Journal: Journal of Alzheimer's disease : JAD
Published: August 17, 2013
Last Updated: 09/26/2026